| 1BHF | A: | P56LCK SH2 DOMAIN INHIBITOR COMPLEX |
| 1BHH | A:; B: | FREE P56LCK SH2 DOMAIN |
| 1CWD | L: | HUMAN P56LCK TYROSINE KINASE COMPLEXED WITH PHOSPHOPEPTIDE |
| 1CWE | A:; C: | HUMAN P56LCK TYROSINE KINASE COMPLEXED WITH PHOSPHOPEPTIDE |
| 1FBZ | A:; B: | STRUCTURE-BASED DESIGN OF A NOVEL, OSTEOCLAST-SELECTIVE, NONPEPTIDE SRC SH2 INHIBITOR WITH IN VIVO ANTI-RESORPTIVE ACTIVITY |
| 1IJR | A: | CRYSTAL STRUCTURE OF LCK SH2 COMPLEXED WITH NONPEPTIDE PHOSPHOTYROSINE MIMETIC |
| 1LCJ | A: | SH2 (SRC HOMOLOGY-2) DOMAIN OF HUMAN P56-LCK TYROSINE KINASE COMPLEXED WITH THE 11 RESIDUE PHOSPHOTYROSYL PEPTIDE EPQPYEEIPIYL |
| 1LCK | A:117-226 | SH3-SH2 DOMAIN FRAGMENT OF HUMAN P56-LCK TYROSINE KINASE COMPLEXED WITH THE 10 RESIDUE SYNTHETIC PHOSPHOTYROSYL PEPTIDE TEGQPYQPQPA |
| 1LKK | A: | HUMAN P56-LCK TYROSINE KINASE SH2 DOMAIN IN COMPLEX WITH THE PHOSPHOTYROSYL PEPTIDE AC-PTYR-GLU-GLU-ILE (PYEEI PEPTIDE) |
| 1LKL | A: | HUMAN P56-LCK TYROSINE KINASE SH2 DOMAIN IN COMPLEX WITH THE PHOSPHOTYROSYL PEPTIDE AC-PTYR-GLU-GLU-GLY (PYEEG PEPTIDE) |
| 1X27 | A:119-226; B:119-226; C:119-226; D:119-226; E:119-226; F:119-226 | CRYSTAL STRUCTURE OF LCK SH2-SH3 WITH SH2 BINDING SITE OF P130CAS |
)
)